American Capital Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$59.6M Sell
265,399
-41,557
-14% -$10.4M 3.2% 9
2025
Q4
$73.9M Sell
306,956
-3,897
-1% -$997K 3.26% 7
2025
Q3
$85.1M Sell
310,853
-7,063
-2% -$1.93M 3.39% 7
2025
Q2
$82M Sell
317,916
-76,618
-19% -$18.3M 3.4% 9
2025
Q1
$88.3M Buy
394,534
+1,769
+0.5% +$413K 3.59% 7
2024
Q4
$89.8M Sell
392,765
-66,305
-14% -$16M 3.34% 7
2024
Q3
$112M Sell
459,070
-35,824
-7% -$8M 3.66% 8
2024
Q2
$94.7M Sell
494,894
-1,860
-0.4% -$377K 3.17% 9
2024
Q1
$98.4M Sell
496,754
-4,797
-1% -$879K 3.15% 10
2023
Q4
$86.3M Buy
501,551
+1,289
+0.3% +$198K 2.95% 12
2023
Q3
$74M Buy
500,262
+23,148
+5% +$4.19M 2.85% 13
2023
Q2
$104M Sell
477,114
-41,873
-8% -$9.33M 3.62% 7
2023
Q1
$114M Sell
518,987
-3,957
-0.8% -$858K 4% 8
2022
Q4
$109M Sell
522,944
-2,012
-0.4% -$442K 4.26% 7
2022
Q3
$115M Sell
524,956
-4,993
-0.9% -$1.14M 4.52% 7
2022
Q2
$111M Sell
529,949
-1,186
-0.2% -$252K 4.16% 6
2022
Q1
$129M Sell
531,135
-26,302
-5% -$6.36M 3.8% 8
2021
Q4
$145M Sell
557,437
-1,290
-0.2% -$335K 3.73% 8
2021
Q3
$147M Sell
558,727
-19,493
-3% -$5.33M 3.95% 7
2021
Q2
$143M Sell
578,220
-10,709
-2% -$2.25M 3.99% 7
2021
Q1
$114M Buy
588,929
+2,381
+0.4% +$477K 3.45% 9
2020
Q4
$125M Sell
586,548
-7,253
-1% -$1.45M 3.73% 10
2020
Q3
$102M Sell
593,801
-32,529
-5% -$6.01M 3.74% 7
2020
Q2
$120M Sell
626,330
-666
-0.1% -$109K 4.42% 7
2020
Q1
$92.3M Sell
626,996
-12,224
-2% -$1.95M 4.49% 5
2019
Q4
$99.1M Buy
639,220
+1,029
+0.2% +$148K 4.15% 6
2019
Q3
$86.2M Sell
638,191
-2,725
-0.4% -$357K 3.82% 5
2019
Q2
$78.2M Buy
640,916
+8,915
+1% +$988K 3.35% 12
2019
Q1
$65.7M Sell
632,001
-2,645
-0.4% -$273K 3.05% 13
2018
Q4
$72.3M Sell
634,646
-9,757
-2% -$1.05M 3.86% 7
2018
Q3
$74.3M Buy
644,403
+1,185
+0.2% +$130K 3.25% 9
2018
Q2
$66.6M Buy
643,218
+1,115
+0.2% +$113K 3.44% 6
2018
Q1
$63.2M Sell
642,103
-15,515
-2% -$1.47M 3.6% 6
2017
Q4
$55.7M Buy
657,618
+3,896
+0.6% +$322K 3.35% 9
2017
Q3
$50.3M Buy
653,722
+4,338
+0.7% +$332K 3.14% 8
2017
Q2
$50.6M Sell
649,384
-13,006
-2% -$931K 3.26% 7
2017
Q1
$47.7M Sell
662,390
-10,695
-2% -$739K 3.37% 8
2016
Q4
$41.8M Buy
673,085
+3,527
+0.5% +$216K 3.23% 8
2016
Q3
$43.4M Buy
+669,558
New +$44.6M 3.33% 7
2016
Q2
Sell
-693,930
Closed -$40.1M 156
2016
Q1
$40.1M Buy
693,930
+83,085
+14% +$4.7M 3.5% 5
2015
Q4
$32.8M Buy
610,845
+13,545
+2% +$764K 2.91% 9
2015
Q3
$30.4M Buy
597,300
+15,820
+3% +$852K 3.16% 10
2015
Q2
$32.8M Buy
581,480
+12,350
+2% +$779K 3.12% 9
2015
Q1
$40.9M Sell
569,130
-9,555
-2% -$621K 4.02% 5
2014
Q4
$32.4M Sell
578,685
-17,765
-3% -$928K 3.52% 9
2014
Q3
$29.4M Sell
596,450
-2,900
-0.5% -$148K 3.42% 8
2014
Q2
$30.3M Buy
599,350
+17,200
+3% +$852K 3.41% 7
2014
Q1
$26M Buy
582,150
+17,425
+3% +$783K 3.07% 9
2013
Q4
$26.6M Buy
564,725
+39,600
+8% +$2M 3.29% 9
2013
Q3
$27.7M Buy
525,125
+15,750
+3% +$764K 3.72% 7
2013
Q2
$23M Buy
+509,375
New +$24.2M 3.45% 7

Other funds holding RMD

American Capital Management's RMD Position: Q1 2026 in Review

American Capital Management reduced its ResMed (RMD) stake by 14% in Q1 2026, selling an estimated $10.4M and leaving 265,399 shares worth $59.6M. The position accounts for 3.2% of the portfolio, ranked #9.

American Capital Management first reported a position in RMD in Q2 2013 and has held it in 51 quarters since. The position peaked at $147M in Q3 2021. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • American Capital Management held 265,399 shares of ResMed worth $59.6M as of Q1 2026.
  • American Capital Management sold 41,557 ResMed shares in Q1 2026, an estimated $10.4M.
  • ResMed made up 3.2% of American Capital Management's portfolio in Q1 2026, its #9 holding.
  • American Capital Management first reported a position in ResMed in Q2 2013 and has held it in 51 quarters since.
  • American Capital Management's ResMed position peaked at $147M in Q3 2021.
  • 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on American Capital Management's 13F filing for Q1 2026, filed 15 May 2026.